Pfizer: board of directors approves quarterly cash dividend of $0.43 per share

Pfizer Inc. (NYSE: PFE) announced that its board of directors has declared a quarterly cash dividend of $0.43 per share for the second quarter of 2026, payable on June 12, 2026, to shareholders of record as of May 8, 2026. This marks the 350th consecutive quarterly dividend paid by the company, underscoring its long-standing commitment to returning value to shareholders.

The dividend increase reflects a continuation of Pfizer’s trend of gradually raising its payout to shareholders. Over the past several years, the company has consistently increased its dividend, with the most recent increase in 2023 raising the quarterly payment to $0.41 per share. The current payout of $0.43 per share represents a 4.88% increase from the previous quarter’s dividend.

Pfizer’s dividend yield currently stands at 6.82%, based on its annual dividend of $1.72 per share. However, the company’s payout ratio of 130.54% indicates that it is distributing more in dividends than it earns in net income, which may raise concerns about long-term sustainability if earnings do not keep pace with dividend growth.

Despite this, Pfizer has maintained a consistent dividend growth trajectory for 17 consecutive years, demonstrating its ability to sustain and increase payouts even amid fluctuating market conditions. The company’s dividend history shows an average annual growth rate of 1.78% over the past 12 months and 2.37% over the past five years.

The ex-dividend date for this dividend is May 8, 2026, meaning investors must purchase shares before this date to be eligible for the June 12, 2026, payment. The announcement reaffirms Pfizer’s role as a reliable income-generating stock for long-term investors, though it also highlights the importance of monitoring the company’s financial performance and earnings trends to assess the sustainability of future dividend increases.